Construction and comparison of five risk prediction models for delay in seeking medical care in patients with acute ischemic stroke based on machine learningAbstract:Objective To construct and compare five risk prediction models for delay in seeking medical care in patients with acute ischemic stroke(AIS)based machine learning,so as to provide support for early identification of high-risk patients in clinical practice.Methods Convenience sampling was used to select 380 AIS patients who visited the Emergency Department of Northern Jiangsu People's Hospital from November 2023 to March 2024 as study subjects.Using stratified sampling,patients were randomly divided into a training set(n=266)and a validation set(n=114)in a 7∶3 ratio.An additional 120 AIS patients who visited the Emergency Department of Northern Jiangsu People's Hospital from April to June 2024 were selected as the test set.Missing values were imputed using the mean method and random interpolation method.Single-factor analysis was employed to examine the factors influencing delay in seeking medical care.Feature selection was performed using the least absolute shrinkage and selection operator(LASSO)regression analysis.Data imbalance was addressed using a linear function normalization method,and five machine learning models were constructed,including Logistic regression,random forest,gradient boosting tree,bootstrap aggvegating(Bagging),and extreme gradient boosting(XGBoost).The correlation between variables was analyzed by drawing a heat map.Model performance was evaluated based on the area under the receiver operating characteristic curve(AUC),accuracy,sensitivity,specificity,F1 score,and decision curve.A variable feature importance map was generated for the optimal model.Results Single-factor and LASSO regression analysis of the training set collectively identified 16 risk factors.The heat map results indicated that correlations among variables were generally weak and did not exhibit significant multicollinearity.The AUC of the five machine learning models ranged from 0.825 to 0.945,with sensitivities between 0.810 and 0.967,specificities from 0.842 to 0.991,accuracies between 0.765 and 0.959,and F1 scores from 0.785 to 0.964.Among these,the XGBoost model emerged as the optimal model,achieving AUC of 0.946 for the validation set and 0.931 for the test set.The decision curve analysis further demonstrated its superior clinical net benefit across most threshold intervals,indicating robust stability.The top 10 risk factors ranked by importance were as follows:Stroke Pre-Hospital Delay Behavior Intention Scale scores,whether there were others around the patient at the time of onset,level of stroke cognition,smoothness of hospital green channels,mode of transport,time of onset,whether the patient knew to use the balance-eyes-face-arm-speech-time(BEFAST)method for stroke recognition,whether the patient experienced transfer or referral,monthly per capita household income and whether family members knew to use BEFAST for stroke recognition.Conclusions Among five machine learning algorithms,the XGBoost model demonstrates optimal predictive performance,aiding healthcare professionals in early identification of patients at high risk for delay in seeking medical care and providing a scientific basis for formulating precise intervention strategies.
Development and psychometrics of the Rating Scale for Schizophrenic Features in WritingsAbstract:Objective To develop the Rating Scale for Schizophrenic Features in Writings(RSFiW)and analyze its reliability and validity.Methods The preliminary scale was developed by combining literature review and comparing the written language characteristics of 30 patients with schizophrenia hospitalized in Chongqing Mental Health Center from April 2015 to August 2018 with 32 healthy subjects recruited externally between September 2018 and April 2021.The preliminary scale was used to assess 157 patients with schizophrenia(from inpatients of several mental hospitals in Chongqing between September 2018 and April 2021)to carry out item analysis and exploratory factor analysis.Confirmatory factor analysis and internal consistency testing were conducted with an additional 154 patients(Inpatient and outpatient patients with schizophrenia in Chongqing Mental Health Center during the same period of time)rated with the adjusted scale.Criterion validity was tested using the Positive and Negative Syndrome Scale and the Scale for Thought,Language,and Communication as validity scales.Results The scale contained 15 items that were decomposed into 5 factors of casual-deliberate,planned,fluent,offset,and redundant-abbreviated,explaining 53.912%of the total variance.Confirmatory factor analysis showed a good model fit(χ2/df=1.248,CFI=0.930,TLI=0.901,SRMR=0.071,RMSEA=0.040).Cronbach's α for the total scale was 0.565.Content validity was good.The factor scores correlated with some of the factor scores of the validity scale.Retest reliability Spearman r was 0.546.The inter-rater reliability for most items were moderate to strong with statistical differences(weighted Kappa=0.325-0.787,P<0.05).The area under the receiver operating characteristic(ROC)curve was 0.999(P<0.001).When the maximum cutoff point of the Youden index was 5.5,the sensitivity was 99.4%and the specificity was 96.9%.Conclusions The development process of this scale is reasonable,and the reliability and validity are acceptable.
Differential diagnostic value of combined detection of serum zonulin and claudin-5 for melancholic versus atypical depressive disorderAbstract:Objective To explore the differences in levels of serum zonulin and claudin-5 between melancholic and atypical depressive disorder and their clinical significance for subtype differentiation.Methods From March 2023 to June 2024,42 cases each of melancholic and atypical depressive disorder patients meeting the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders(5th edition)(DSM-5)in the outpatient department of Beijing Huilongguan Hospital were selected as melancholic group and atypical group,and 40 cases of healthy volunteers who had medical checkups in the hospital during the same time period were selected as healthy control group.The severity of the patients'depressive disorder was assessed using the 17-item version of the Hamilton Depression Scale(HAMD-17).Serum zonulin and claudin-5 levels were measured in the three groups using enzyme-linked immunosorbent assay to compare the differences between the groups.The differential diagnostic value of the two proteins alone and in combination for the two subtypes of depressive disorder was also assessed using the receiver operating characteristic(ROC)curve.Results The serum zonulin levels in melancholic,atypical,and healthy control groups were 1 040.69(827.23,1 348.38)ng/ml,748.38(146.46,954.15)ng/ml,543.86(361.84,1 015.35)ng/ml,and the claudin-5 levels were 194.20(161.79,268.28)pg/ml,164.57(36.33,205.77)pg/ml,and 118.60(84.86,190.40)pg/ml,and the differences between the three groups were statistically significant(all P<0.05).The levels of both serum proteins were higher in melancholic group than those in atypical group and healthy control group with statistical differences(both P<0.05).There was no statistically significant difference in the levels of the two serum proteins between atypical group and healthy control group(both P>0.05).The area under the ROC curve for serum zonulin to differentiate between melancholic and atypical depressive disorder was 0.741[95%confidence interval(95%CI)(0.635,0.847),P<0.05],with a sensitivity of 64.3%and a specificity of 76.2%.The area under the ROC curve for serum claudin-5 prediction was 0.679[95%CI(0.564,0.793),P<0.05],with a sensitivity of 92.9%and a specificity of 35.7%.The area under the ROC curve for the combined prediction of the two proteins was 0.815[95%CI(0.723,0.908),P<0.05)],with a sensitivity of 85.7%and a specificity of 71.4%.Conclusions Two proteins,serum zonulin and claudin-5,are higher in patients with melancholic depressive disorder than those in patients with atypical depressive disorder and may be effective biomarkers for differential diagnosis of the two subtypes.Zonulin combined with claudin-5 has high clinical value for subtype differential diagnosis.
Research progress on EGFR mutations and targeted therapy in gliomaAbstract:Gliomas are primary tumors originating from intracranial glial cells and is also one of the most common malignant intracranial tumors.The initiation and progression are often accompanied by genetic mutations,among which 40%to 60%of gliomas have epidermal growth factor receptor(EGFR)mutations.The abnormal expression and sustained activation of EGFR promote tumor cell proliferation,migration,and survival through various downstream signaling pathways,and EGFR mutations in gliomas typically indicate poor overall survival.Therefore,EGFR targeted therapy for glioma is of great significance.A comprehensive understanding of the role and mechanisms of EGFR mutations in the initiation and progression of gliomas can help further refine potential EGFR targeted treatment strategies.
Evidence summary of blood pressure management during intravenous thrombolysis in patients with acute ischemic strokeAbstract:Objective To analyze the evidence on blood pressure management during intravenous thrombolysis in patients with acute ischemic stroke.Methods Evidence on target blood pressure management during intravenous thrombolysis in patients with acute ischemic stroke was electronically and systematically retrieved from China National Knowledge Infrastructure,WanFang Data,VIP,and China Biomedical Literature Database,PubMed,Cochrane Library,Embase,Web of Science,BMJ Best Practice,Ovid,UpToDate,and international authoritative websites,such as the Chinese Nursing Association,Guidelines International Network,National Institute for Health and Clinical Excellence,Scottish Intercollegiate Guidelines Network,American Stroke Association,Canadian Stroke Organization,and European Stroke Organisation.The search period was from the establishment of the database to April 30,2025.Two researchers independently conducted literature screening,quality evaluation,and evidence level assessment.Results A total of 14 articles were included,including 6 clinical guidelines,2 expert consensus,1 group standard,2 systematic reviews,1 evidence summary,1 clinical decision,and 1 best practice recommendation.A total of 23 pieces of evidence were extracted from 14 articles and integrated into 7 dimensions,including basic principles,control objectives,selection and maintenance of venous access,nursing of vasoactive drugs,nursing of thrombolytic drugs,blood pressure monitoring,and prevention and management of complications.Conclusions The evidence in this study mainly comes from domestic and international clinical guidelines,expert consensus,and clinical decision,with a high level of evidence and credibility.It is recommended that when conducting evidence transformation in clinical practice,factors such as the patient's age,underlying disease,and stroke time should be fully considered to selectively apply evidence,and scientifically manage the blood pressure during intravenous thrombolysis in patients with acute ischemic stroke,thereby improving patient prognosis.
Research progress on prognosis,prevention and treatment of stroke-related sarcopeniaAbstract:Stroke-related sarcopenia(SRS)seriously affects the quality of life and long-term prognosis of patients.SRS is a key independent risk factor for poor prognosis in stroke,and their coexistence can significantly impair patients'ability of daily living,cognitive function,exacerbate neurological deficits,and increase the risk of complications and stroke recurrence.This paper reviews the prognostic factors,treatment,prevention,and rehabilitation of SRS,providing a reference for developing precise intervention strategies in clinical practice to improve the outcomes of high-risk patients.
Current status and treatment progress of psychiatric drug-induced leukopeniaAbstract:White blood cells,especially neutrophils,are crucial for defending against infections caused by important pathogens such as bacteria and fungi.When it is significantly reduced,life-threatening complications may occur.In clinical practice,leukopenia/neutropenia caused by non-chemotherapy drugs is often asymptomatic in its early stages,making it difficult to detect promptly and potentially leading to serious complications.Nearly all major categories of psychiatric drugs are associated with leukopenia/neutropenia,which may occur at any time during treatment,and the risk is difficult to predict.Therefore,enhancing awareness of psychiatric drug-induced leukopenia/neutropenia is particularly important for psychiatrists.This article provides a review of the incidence,clinical characteristics,mechanisms,and conventional treatment methods for leukopenia/neutropenia induced by commonly psychiatric drugs.
Research progress on speech features of patients with mental illnessAbstract:The symptoms of mental illness are mostly associated with changes in speech.Speech is an integration of cognitive and physiological information.Its recording equipment is simple,and patients find it difficult to conceal symptoms,making it an excellent objective biomarker for mental illness.This paper reviews the speech features and development trends of common mental illnesses in recent years.Currently,phonetic research requires large-scale longitudinal studies to identify speech features associated with disorders such as personality disorders,so as to enable the establishment of association with other biological markers,thereby advancing the development of multimodal health technologies and remote screening tools.
Research progress on clinical characteristics and treatment of comorbidity of bipolar disorder and other mental disorders in children and adolescentsAbstract:Bipolar disorder(BD)is a common affective disorder in children and adolescents and is frequently co-morbid with other mental disorders.Comorbidity often poses significant challenges to the diagnosis,treatment,and prognosis of diseases.This paper reviews the epidemiology,clinical characteristics,and treatment of comorbidities of mental disorders in children and adolescents,including BD,attention deficit/hyperactivity disorder,autism spectrum disorder,obsessive compulsive disorder,and substance use disorder,aiming to provide reference for clinical diagnosis and treatment.
Relationship between D-dimer/fibrinogen,triglycerides/high-density lipoprotein and blood pressure variability and cognitive function in patients with acute cerebral infarction and hypertensionAbstract:Objective To investigate the relationship between D-dimer/fibrinogen,triglycerides/high-density lipoprotein,and blood pressure variability and cognitive impairment in patients with acute cerebral infarction and hypertension.Methods From September 2023 to June 2024,100 patients with acute cerebral infarction and hypertension admitted to Beijing Shunyi Hospital were selected as the study group.According to the Montreal Cognitive Assessment(MoCA)score,the patients were divided into cognitive impairment group(MoCA score<26,n=48)and non-cognitive impairment group(MoCA score 26 to 30,n=52).Acute cerebral infarction patients(n=100)admitted to our hospital during the same period were selected as the control group.Data were collected from two groups regarding age,gender,body mass index,infarct site,infarct volume,educational level,National Institutes of Health Stroke Scale(NIHSS)score,total cholesterol,triglycerides,low-density lipoprotein,high-density lipoprotein,D-dimer,and fibrinogen.Pearson correlation was used to examine the relationship between D-dimer/fibrinogen,triglycerides/high-density lipoprotein,and blood pressure variability in patients.Logistic regression was employed to analyze factors influencing cognitive impairment in patients with acute cerebral infarction and hypertension.Receiver operating characteristic(ROC)curves were used to analyze the value of D-dimer/fibrinogen and triglycerides/high-density lipoprotein in assessing cognitive impairment among patients with acute cerebral infarction and hypertension.Results There were statistically significant differences between study group and control group in terms of D-dimer[(0.48±0.09)mg/L vs.(0.41±0.06)mg/L],fibrinogen[(3.46±0.51)g/L vs.(2.89±0.40)g/L],triglycerides[(1.76±0.32)mmol/L vs.(1.38±0.24)mmol/L],and D-dimer/fibrinogen[(16.43±3.51)×10-5 vs.(13.24±2.76)×10-5],triglycerides/high-density lipoprotein[(1.65±0.47)vs.(1.13±0.33)],24-hour systolic coefficient of variation(SCV)[(12.54±2.97)%vs.(10.12±2.20)%],and 24-hour diastolic coefficient of variation(DCV)[(15.09±3.16)%vs.(11.44±2.20)%](t=6.472,8.794,9.500,7.144,9.055,6.548,8.805;all P<0.001).Pearson correlation analysis revealed that D-dimer/fibrinogen and triglycerides/high-density lipoprotein were both positively correlated with 24-hour SCV and 24-hour DCV(r=0.542,0.424,0.562,0.396;all P<0.001).There were statistically significant differences between cognitive impairment group and non-cognitive impairment group in terms of D-dimer[(0.52±0.11)mg/L vs.(0.44±0.07)mg/L],fibrinogen[(3.57±0.55)g/L vs.(3.36±0.47)g/L],triglycerides[(1.85±0.34)mmol/L vs.(1.68±0.30)mmol/L],D-dimer/fibrinogen[(18.23±3.91)×10-5 vs.(14.77±3.14)×10-5],triglycerides/high-density lipoprotein[(1.87±0.51)vs.(1.45±0.43)],24-hour SCV[(13.68±3.22)%vs.(11.49±2.74)%]and 24-hour DCV[(16.29±3.43)%vs.(13.98±2.91)%](t=4.373,2.057,2.656,4.897,4.464,3.672,3.641;all P<0.05).Logistic regression analysis showed that D-dimer/fibrinogen[OR=1.874,95%CI(1.230,2.856)],triglycerides/high-density lipoprotein[OR=1.756,95%CI(1.093,2.822)],and 24-hour SCV[OR=1.715,95%CI(1.038,2.833)]were factors affecting cognitive impairment in patients,and the differences were statistically significant(all P<0.05).The combined area under the curve(AUC)for D-dimer/fibrinogen and triglycerides/high-density lipoprotein in predicting cognitive impairment was 0.901,superior to either single test,and the differences were statistically significant(ZD-dimer/fibrinogen-combined=3.080,P=0.002;Ztriglycerides/high-density lipoprotein-combined=3.223,P=0.001).Conclusions D-dimer/fibrinogen,triglycerides/high-density lipoprotein are positively correlated with blood pressure variability in patients with acute cerebral infarction and hypertension.Furthermore,elevated levels of these biomarkers were identified as significant risk factors for cognitive impairment.
Clinical characteristics of anxiety symptoms in late-life depression patients with suicide risk at the acute phaseAbstract:Objective To investigate the clinical characteristics and associated factors of suicide risk and anxiety symptoms in late-life depression(LLD)patients at the acute phase.Methods A cross-sectional observational study was conducted to analyze data of 117 LLD patients accompanied by suicide risk and anxiety symptoms hospitalized at Beijing Anding Hospital affiliated with Capital Medical University between July 2021 and May 2022.This study collected patients'general information,clinical characteristics,cognitive function,five thyroid function parameters,adrenocorticotropic hormone,cortisol,total cholesterol,triglycerides,high-density lipoprotein cholesterol,low-density lipoprotein cholesterol,and sex hormone levels.Hamilton Anxiety Rating Scale(HAMA),Hamilton Depression Rating Scale-24(HAMD-24),and Montreal Cognitive Assessment(MoCA)were used to evaluate anxiety,depressive symptoms,and cognitive function.According to the total score of HAMA,patients were divided into mild anxiety group(HAMA score 14-<21,n=47)and moderate to severe anxiety group(HAMA score≥21,n=70).Clinical symptoms,cognitive function,and endocrine hormone levels were compared between the two groups.Logistic regression was used to analyze risk factors for moderate-to-severe anxiety symptoms.Results Compared with patients with mild anxiety,those with moderate to severe anxiety had a higher proportion of married individuals[84.29%(59/70)vs.68.09%(32/47),χ2=4.270]and a higher proportion of prior history of traumatic brain injury[22.86%(16/70)vs.6.38%(3/47),χ2=5.611],higher scores on the HAMD anxiety/somatization factor[9.00(7.00,11.00)vs.8.00(6.00,9.00),Z=-3.259],and sleep disturbance factor[6.00(4.75,7.25)vs.6.00(3.00,6.00),Z=-2.182],and higher total HAMD-24 scores[30.00(27.00,37.25)vs.27.00(24.00,30.00),Z=-4.058],and higher scores on the HAMA psychotic anxiety factor[14.00(12.75,17.00)vs.11.00(10.00,12.00),Z=-6.687]and somatic anxiety factor[17.00(15.00,20.00)vs.13.00(12.00,14.00),Z=-6.352],and lower MoCA total scores[(17.51±4.80)vs.(20.10±4.67)t=2.249],and all differences were statistically significant(all P<0.05).Logistic regression analysis revealed that the anxiety/somatization factor was a statistically significant risk factor of moderate-to-severe anxiety in LLD patients with suicide risk[OR=1.636,95%CI(1.030,2.599),P=0.037].Conclusions Among LLD patients with suicide risk and anxiety symptoms at the acute phase,those with moderate to severe anxiety are often married,have a history of traumatic brain injury,have severe depressive symptoms,and low cognitive function.The anxiety/somatization factor is a risk factor for moderate to severe anxiety symptoms.
Clinical application of functional near-infrared spectroscopy in distinguishing simple GAD from comorbidity ADHDAbstract:Objective To explore the clinical application of functional near-infrared spectroscopy(fNIRS)in distinguishing patients with generalized anxiety disorder(GAD)alone from those GAD comorbid with attention deficit hyperactivity disorder(ADHD).Methods From October 2023 to May 2024,34 adult patients with GAD alone were recruited as a control group,and 35 adult patients with GAD comorbid with ADHD were recruited as a study group from the outpatient and inpatient departments of the Second People's Hospital of Guizhou Province.The Adult ADHD Self-Report Scale(ASRS)was used to assess participants'attention deficit and hyperactivity/impulsivity symptoms,while the Generalized Anxiety Disorder-7(GAD-7)was employed to evaluate anxiety symptoms.FNIRS based on the 1-BACK task was used to detect changes in oxy-hemoglobin(Oxy-Hb)concentration in the prefrontal cortex(PFC)of both groups.Results The scores of the ASRS attention deficit subscale,hyperactivity subscale,and GAD-7 in study group were higher than those in control group,and the differences were statistically significant(all P<0.05).Behavioral data indicated that there were no statistically significant differences in reaction time and accuracy between the two groups during the 1-BACK task(all P>0.05).During the 1-BACK task,compared with control group,patients in study group exhibited statistically enhanced activation in multiple regions of PFC[false discovery rate(FDR)-corrected P<0.05],including the triangular inferior frontal gyrus(channels 7,8,9),middle frontal gyrus(channels 15,43),dorsolateral superior frontal gyrus(channels 16,17),and precentral gyrus(channel 11).However,when conducting a rank ANCOVA analysis with GAD-7 scores as a covariate to control for anxiety severity,all previously observed between-group channel differences were found to be statistically insignificant(all P>0.05).Additionally,the effect of GAD-7 as a covariate did not reach statistical significance across all channels(all FDR-corrected P>0.05).Conclusions The severity of anxiety may serve as a key mediating variable influencing prefrontal cortical activation.When utilizing fNIRS to distinguish between GAD alone and GAD comorbid with ADHD,careful control of this confounding factor is essential.
Research progress on biomarkers for predicting the efficacy of repetitive transcranial magnetic stimulation in depressive disordersAbstract:Repetitive transcranial magnetic stimulation(rTMS)is a widely used non-invasive neuromodulation method for the treatment of depressive disorders.Ineffective rTMS imposes significant financial and psychological burdens on patients with depressive disorders,hence the urgent need for reliable predictive biomarkers to predict clinical efficacy.This paper summarizes and discusses the electrophysiological and imaging biomarkers for predicting the efficacy of rTMS for depressive disorders,aiming to provide theoretical support to guide clinical practice in the treatment of depressive disorders.
Changes in serum IL-18 levels and their correlation with clinical symptoms in first-episode drug-naive adolescent schizophreniaAbstract:Objective To explore the characteristics of serum IL-18 levels in first-episode drug-naive adolescent schizophrenia(FEDNAS)patients and their correlation with clinical symptoms,so as to assess the potential of IL-18 to predict disease risk.Methods This study was a cross-sectional study.From September 2021 to June 2024,99 patients with FEDNAS were recruited at the Fourth People's Hospital of Lianyungang,Kangda College of Nanjing Medical University to form the patient group.Concurrently,40 healthy controls matched for age and gender,assessed as having no history of psychiatric disorders,were recruited locally to form the control group.Serum IL-18 concentrations were measured in all subjects.The Positive and Negative Symptom Scale(PANSS)was used to assess patients'clinical symptoms.The correlation between IL-18 levels and the symptom severity and duration of schizophrenia was analyzed.t-test,χ2 test,analysis of covariance,and Pearson/Spearman correlation analysis were used to evaluate between-group differences and variable correlations.Multiple linear regression was used to analyze the correlation between IL-18 and cognitive symptoms.Relative risk was calculated using modified Poisson regression,and attributable fractions and population attributable fractions were also computed.Results Eleven patients(11.11%,11/99)in patient group had a family history of mental illness.The total PANSS score of the patient was(80.65±15.85).The serum IL-18 concentration in patient group(157.85±55.39)pg/ml was statistically lower than that in control group(194.07±62.57)pg/ml(F=12.952,P<0.001,Cohen's d=0.63).The level of IL-18 in FEDNAS patients was negatively correlated with PANSS cognitive factor score(r=-0.357,P<0.001),and positively correlated with disease duration(rs=0.235,P=0.019),with statistical differences.The IL-18 level in patients with a disease course of<2 years was statistically lower than that in control group(F=7.905,P=0.001).Based on the results of univariate analysis,all participants'IL-18 levels were divided into a high-expression group(above the 67%quantile)and a low-expression group(below the 67%quantile)according to the 67%quantile.Modified Poisson regression analysis revealed that low IL-18 expression was statistically associated with the risk of FEDNAS[RR=0.989,95%CI(0.986,0.991),P<0.001].The attributable fraction(AF)calculations indicated that low IL-18 expression reduced the individual risk of disease onset by approximately 1.11%,with a population attributable fraction(PAF)of-0.74%.Conclusions Serum IL-18 levels in FEDNAS patients are lower than those in healthy controls,exhibiting a negative correlation with cognitive symptoms and showing pronounced changes in the early disease stage(<2 years).This suggests that decreased IL-18 levels may reflect an immune response pattern specific to the early disease stage and participate in the pathological process of cognitive impairment in FEDNAS.
Small fiber neuropathy in primary Sjögren's syndrome initially considered as psychosomatic symptoms:a case report and literature reviewAnalysis of the relationship between hypothalamic-pituitary-thyroid axis hormones and inflammatory factors and the risk of non-suicidal self-injury in adolescents based on a binary Logistic regression modelAbstract:Objective To explore the changes in hypothalamic-pituitary-thyroid(HPT)axis hormones and inflammatory factor levels in non-suicidal self-injury(NSSI)adolescents,and investigate the risk relationship with NSSI in adolescents.Methods A total of 62 depressive disorder adolescents who visited the Outpatient Department of Inner Mongolia Mental Health Center from March 2024 to May 2025 were selected as research subjects.Patients were divided into a depression-only group(n=19)and a depression-with-NSSI group(n=43)based on the presence of NSSI.Levels of HPT axis hormones and inflammatory factors were measured by collecting blood samples from the elbow vein.A binary Logistic regression model was used to construct a risk prediction model for adolescent NSSI based on HPT axis and inflammatory factors,and a receiver operating characteristic(ROC)curve was plotted.The predictive performance of the diagnostic model was evaluated using the area under the curve(AUC),optimal cutoff value,sensitivity and specificity.Results Compared with depression-only group,depression-with-NSSI group exhibited decreased thyroid-stimulating hormone(TSH)levels[(1.50±0.79)vs.(2.41±1.40);t=3.267,P=0.002],and increased neutrophil-to-lymphocyte ratio(NLR)levels[(2.29±1.29)vs.(1.39±0.44);t=-2.942,P=0.005],with statistically significant differences.Binary Logistic regression analysis revealed that decreased TSH[OR=0.415,95%CI(0.212,0.813),P=0.010]and increased NLR[OR=16.941,95%CI(1.586,180.996),P=0.019]were statistically associated with an increased risk of adolescent NSSI.ROC curve analysis revealed that the AUC for predicting adolescent NSSI risk were 0.690 for TSH and 0.715 for NLR,with a combined AUC of 0.794(P<0.05).Conclusions Both TSH and the inflammatory factor NLR are independent predictors of NSSI in adolescents,and have predictive effects on the risk of NSSI in adolescents.
Research progress on CLDN5 gene in depressive disorderAbstract:Claudin 5(CLDN5)is a key structural component of intercellular tight junction proteins and has been identified as one of the most important intercellular tight junction proteins in the blood-cerebrospinal fluid barrier.Numerous studies have demonstrated that blood-cerebrospinal fluid barrier dysfunction is an important mechanism in the occurrence and progression of depressive disorder.CLDN5,one of the most important intercellular tight junction proteins in the blood-cerebrospinal fluid barrier,has also received much attention.This paper reviews the relationship between CLDN5 gene and the occurrence and treatment of depressive disorder,aiming to provide a reference for future research.
Factors influencing the severity of hyperhomocysteinemia in late-life schizophreniaAbstract:Objective To explore the severity of hyperhomocysteinemia(HHcy)among late-life schizophrenia(LLS)and to analyze its risk factors.Methods A retrospective study was conducted on 380 LLS and HHcy who were hospitalized at Nanjing Youan Hospital from January 1,2024 to January 1,2025.Demographic data,past medical history,medication,biochemical tests,and scale scores were collected by reviewing patient case records.Patients were categorized into three groups based on HHcy severity:mild group(Hcy10-<15 μmol/L,n=156),moderate group(Hcy15-≤30 μmol/L,n=167),and severe group(Hcy>30 μmol/L,n=57).Univariate analysis was performed to analyze the general information of the three groups of patients.The variables with statistically significant differences(P<0.05)and variance inflation factor<5 in univariate analysis were included in the multivariate Logistic regression model to further analyze the risk factors influencing the severity of HHcy in elderly patients with schizophrenia.Results Univariate analysis revealed statistically significant differences among the three groups of patients in age,gender,weight,body mass index,triglycerides,total cholesterol,apolipoprotein B,uric acid,and cystatin C(all P<0.05).Multivariate Logistic regression analysis showed that,using mild group as a reference increasing age[OR=1.04,95%CI(1.00,1.09),P<0.05],increased body mass index[OR=1.18,95%CI(1.10,1.27),P<0.01],elevated total cholesterol[OR=1.47,95%CI(1.10,1.95),P<0.01],elevated cystatin C[OR=6.37,95%CI(2.00,20.27),P<0.01]were risk factors for progression from mild to moderate severity,while female sex[OR=0.54,95%CI(0.32,0.93),P<0.05]was a protective factor.While using moderate group as a reference,Elevated total cholesterol[OR=5.99,95%CI(3.53,10.18),P<0.01]and elevated cystatin C[OR=14.30,95%CI(2.44,83.76),P<0.01]were risk factors for moderate to severe progression,while female sex[OR=0.24,95%CI(0.09,0.67),P<0.01]was a protective factor.Conclusions This study indicates that LLS exhibit a high prevalence of HHcy,with its severity influenced by multiple factors.Male gender,advanced age,elevated body mass index,total cholesterol,and cystatin C are independent risk factors,and the impact of total cholesterol intensifies with increasing disease severity.
Risk prediction models for violent aggressive behavior in patients with schizophrenia spectrum disorders:a scoping reviewAbstract:Objective To conduct a scoping review on risk prediction models for violent aggression behavior in patients with schizophrenia spectrum disorders,so as to inform future research and clinical decision-making.Methods Risk prediction models for violent aggression behavior in patients with schizophrenia spectrum disorders were systematically searched in 9 Chinese and English databases,including Chinese Biomedical Literature Data,China National Knowledge Infrastructure,VIP,WanFang Data,PubMed,Cochrane Library,CINAHL,Embase,and Web of Science.The search period was from January 1,2014 to July 6,2024.Data on modeling methods,validation and presentation formats,predictors,and predictive performance were extracted,and standardized reporting was conducted.Results A total of 18 articles were included,and the sample size of model construction ranged from 57 to 1 426.The incidence of violent aggression behavior in patients with schizophrenia spectrum disorders was from 24%to 79.70%.Logistic regression and various machine learning algorithm models were employed,with supervised machine learning method demonstrating the best performance in predicting such behavior.Common predictors included history of violent aggression behavior,negative symptoms,history of antipsychotic medication use,age,hospital stay,educational level and adherence.Conclusions Existing predictive models demonstrate some effectiveness in forecasting violent aggression behavior among individuals with schizophrenia spectrum disorders.In the context of artificial intelligence,multimodal clinical prediction models should be utilized to conduct accurate risk assessments of such behaviors and optimize the key influencing factors contributing to their occurrence,and thereby providing a basis for early clinical intervention decisions.
Research progress on the impact of Toxoplasma gondii infection on schizophreniaAbstract:Schizophrenia results from the interaction of environmental,individual,genetic,and immune factors,and is also associated with epigenetic modifications.Toxoplasma gondii is a widely distributed obligate intracellular parasite in nature.Approximately one-third of the global population has been infected with Toxoplasma gondii,but most cases are inapparent infections,with an infection rate of about 8%in China.Meta-analysis,ecological studies,and large-scale observational research indicate an association between Toxoplasma gondii infection and an increased risk of schizophrenia.However,as the pathogenesis of schizophrenia remains unclear,research into the impact of Toxoplasma gondii infection on schizophrenia has become a hot topic.Current mechanistic studies primarily focus on neuroinflammation and alterations in neurotransmitter systems,though definitive conclusions have yet to be reached.This review aims to systematically present research progress on the impact of Toxoplasma gondii infection on schizophrenia from epidemiological,immunological,and genetic perspectives,providing a reference for the early diagnosis of Toxoplasma gondii infection in patients with schizophrenia.